P20749 (BCL3_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 135.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: B-cell lymphoma 3 protein Short name=BCL-3 Alternative name(s): Proto-oncogene BCL3 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 454 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Contributes to the regulation of transcriptional activation of NF-kappa-B target genes. In the cytoplasm, inhibits the nuclear translocation of the NF-kappa-B p50 subunit. In the nucleus, acts as transcriptional activator that promotes transcription of NF-kappa-B target genes. Contributes to the regulation of cell proliferation By similarity. Ref.4 |
| Subunit structure | Component of a complex consisting of the NF-kappa-B p52-p52 homodimer and BCL3. Component of a complex consisting of the NF-kappa-B p50-p50 homodimer and BCL3. Interacts with N4BP2, COPS5 and PIR. Interacts with CYLD By similarity. Ref.4 Ref.5 Ref.6 Ref.7 |
| Subcellular location | Nucleus. Cytoplasm By similarity. Cytoplasm › perinuclear region By similarity. Note: Ubiquitination via 'Lys-63'-linked ubiquitin chains is required for nuclear accumulation By similarity. |
| Post-translational modification | Polyubiquitinated. Ubiquitination via 'Lys-63'-linked ubiquitin chains is required for nuclear accumulation. Deubiquitinated by CYLD, which acts on 'Lys-63'-linked ubiquitin chains. Deubiquitination by CYLD prevents nuclear accumulation By similarity. Activated by phosphorylation. |
| Involvement in disease | A chromosomal aberration involving BCL3 may be a cause of B-cell chronic lymphocytic leukemia (B-CLL). Translocation t(14;19)(q32;q13.1) with immunoglobulin gene regions. |
| Sequence similarities | Contains 7 ANK repeats. |
| Caution | It is uncertain whether Met-1 or Met-9 is the initiator. |
| Sequence caution | The sequence AAA51815.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. The sequence AAA51816.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. The sequence AAH64993.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| BCL10 | O95999 | 3 | EBI-958997,EBI-958922 | |
| CTBP2 | P56545 | 2 | EBI-958997,EBI-741533 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 454 | 454 | B-cell lymphoma 3 protein | PRO_0000066976 | |||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||
| Repeat | 134 – 163 | 30 | ANK 1 | ||||||||||||||||||||||||||||||||||||
| Repeat | 171 – 200 | 30 | ANK 2 | ||||||||||||||||||||||||||||||||||||
| Repeat | 204 – 235 | 32 | ANK 3 | ||||||||||||||||||||||||||||||||||||
| Repeat | 241 – 270 | 30 | ANK 4 | ||||||||||||||||||||||||||||||||||||
| Repeat | 275 – 304 | 30 | ANK 5 | ||||||||||||||||||||||||||||||||||||
| Repeat | 308 – 337 | 30 | ANK 6 | ||||||||||||||||||||||||||||||||||||
| Repeat | 338 – 367 | 30 | ANK 7 | ||||||||||||||||||||||||||||||||||||
| Compositional bias | 9 – 120 | 112 | Pro-rich | ||||||||||||||||||||||||||||||||||||
| Compositional bias | 365 – 454 | 90 | Pro/Ser-rich | ||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||
| Modified residue | 402 | 1 | Phosphoserine; by GSK3 | ||||||||||||||||||||||||||||||||||||
| Modified residue | 406 | 1 | Phosphoserine; by GSK3 Ref.9 | ||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||
| Helix | 138 – 144 | 7 | |||||||||||||||||||||||||||||||||||||
| Helix | 148 – 160 | 13 | |||||||||||||||||||||||||||||||||||||
| Helix | 175 – 181 | 7 | |||||||||||||||||||||||||||||||||||||
| Helix | 185 – 193 | 9 | |||||||||||||||||||||||||||||||||||||
| Helix | 208 – 214 | 7 | |||||||||||||||||||||||||||||||||||||
| Helix | 218 – 227 | 10 | |||||||||||||||||||||||||||||||||||||
| Helix | 245 – 252 | 8 | |||||||||||||||||||||||||||||||||||||
| Helix | 255 – 263 | 9 | |||||||||||||||||||||||||||||||||||||
| Turn | 273 – 275 | 3 | |||||||||||||||||||||||||||||||||||||
| Helix | 279 – 285 | 7 | |||||||||||||||||||||||||||||||||||||
| Helix | 289 – 297 | 9 | |||||||||||||||||||||||||||||||||||||
| Helix | 312 – 319 | 8 | |||||||||||||||||||||||||||||||||||||
| Helix | 322 – 330 | 9 | |||||||||||||||||||||||||||||||||||||
| Turn | 345 – 348 | 4 | |||||||||||||||||||||||||||||||||||||
| Helix | 352 – 358 | 7 | |||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control." Ohno H., Takimoto G., McKeithan T.W. Cell 60:991-997(1990) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]. |
| [2] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Lung. |
| [3] | "Genomic structure of the candidate proto-oncogene BCL3." McKeithan T.W., Ohno H., Dickstein J., Hume E. Genomics 24:120-126(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 87-454. Tissue: Leukemia. |
| [4] | "The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers." Bours V., Franzoso G., Azarenko V., Park S., Kanno T., Brown K., Siebenlist U. Cell 72:729-739(1993) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, IDENTIFICATION IN A COMPLEX WITH NFKB2/P52. |
| [5] | "NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes." Heissmeyer V., Krappmann D., Wulczyn F.G., Scheidereit C. EMBO J. 18:4766-4778(1999) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN A COMPLEX WITH NFKB1/P50. |
| [6] | "The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators." Dechend R., Hirano F., Lehmann K., Heissmeyer V., Ansieau S., Wulczyn F.G., Scheidereit C., Leutz A. Oncogene 18:3316-3323(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH COPS5 AND PIR. |
| [7] | "Identification and characterization of BCL-3-binding protein: implications for transcription and DNA repair or recombination." Watanabe N., Wachi S., Fujita T. J. Biol. Chem. 278:26102-26110(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH N4BP2. |
| [8] | "Crystal structure of the ankyrin repeat domain of Bcl-3: a unique member of the IkappaB protein family." Michel F., Soler-Lopez M., Petosa C., Cramer P., Siebenlist U., Muller C.W. EMBO J. 20:6180-6190(2001) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.86 ANGSTROMS) OF 127-367. |
| [9] | "GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity." Viatour P., Dejardin E., Warnier M., Lair F., Claudio E., Bureau F., Marine J.C., Merville M.P., Maurer U., Green D., Piette J., Siebenlist U., Bours V., Chariot A. Mol. Cell 16:35-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-404 AND SER-406. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M31731 Genomic DNA. Translation: AAA51816.1. Different initiation. M31732 mRNA. Translation: AAA51815.1. Different initiation. AC092066 Genomic DNA. No translation available. BC064993 mRNA. Translation: AAH64993.1. Different initiation. AH006679 Genomic DNA. Translation: AAC51348.1. | ||||||||||||||||||
| IPI | IPI00791379. | ||||||||||||||||||
| PIR | A34794. | ||||||||||||||||||
| RefSeq | NP_005169.2. NM_005178.4. | ||||||||||||||||||
| UniGene | Hs.31210. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | P20749. | ||||||||||||||||||
| SMR | P20749. Positions 133-411. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| IntAct | P20749. 3 interactions. | ||||||||||||||||||
| STRING | 9606.ENSP00000164227. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | P20749. | ||||||||||||||||||
Polymorphism databases | |||||||||||||||||||
| DMDM | 294862410. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PaxDb | P20749. | ||||||||||||||||||
| PRIDE | P20749. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000164227; ENSP00000164227; ENSG00000069399. | ||||||||||||||||||
| GeneID | 602. | ||||||||||||||||||
| KEGG | hsa:602. | ||||||||||||||||||
| UCSC | uc010xxe.2. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 602. | ||||||||||||||||||
| GeneCards | GC19P045250. | ||||||||||||||||||
| HGNC | HGNC:998. BCL3. | ||||||||||||||||||
| HPA | CAB002051. | ||||||||||||||||||
| MIM | 109560. gene. | ||||||||||||||||||
| neXtProt | NX_P20749. | ||||||||||||||||||
| PharmGKB | PA25310. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | COG0666. | ||||||||||||||||||
| HOGENOM | HOG000095189. | ||||||||||||||||||
| HOVERGEN | HBG108320. | ||||||||||||||||||
| InParanoid | P20749. | ||||||||||||||||||
| KO | K09258. | ||||||||||||||||||
| OrthoDB | EOG4NCMD1. | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| Pathway_Interaction_DB | nfkappabatypicalpathway. Atypical NF-kappaB pathway. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| Bgee | P20749. | ||||||||||||||||||
| CleanEx | HS_BCL3. | ||||||||||||||||||
| Genevestigator | P20749. | ||||||||||||||||||
| GermOnline | ENSG00000069399. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| Gene3D | 1.25.40.20. 1 hit. | ||||||||||||||||||
| InterPro | IPR002110. Ankyrin_rpt. IPR020683. Ankyrin_rpt-contain_dom. [Graphical view] | ||||||||||||||||||
| Pfam | PF00023. Ank. 4 hits. [Graphical view] | ||||||||||||||||||
| PRINTS | PR01415. ANKYRIN. | ||||||||||||||||||
| SMART | SM00248. ANK. 6 hits. [Graphical view] | ||||||||||||||||||
| SUPFAM | SSF48403. ANK. 1 hit. | ||||||||||||||||||
| PROSITE | PS50297. ANK_REP_REGION. 1 hit. PS50088. ANK_REPEAT. 5 hits. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| EvolutionaryTrace | P20749. | ||||||||||||||||||
| GenomeRNAi | 602. | ||||||||||||||||||
| NextBio | 2447. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | BCL3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P20749 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 19 Human chromosome 19: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
